BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical

Clinical Trial Summary

Part 1 - Evaluate the real-world implementation of extended prophylaxis with betrixaban in the acutely ill hospitalized medical population Part 2 - Describe patterns of Venous thromboembolism (VTE) prophylaxis in acutely ill medical patients who qualify for extended VTE prophylaxis

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05409976` - The GORE® VIAFORT Vascular Stent IVC Study	N/A
Completed	`NCT03015025` - Pharmacogenetic Dosage Algorithm for Acenocoumarol	N/A
Completed	`NCT03911661` - Fearon Algorithm in Warfarin Patient Self-Management	N/A
Recruiting	`NCT05449808` - Evaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients
Withdrawn	`NCT05246943` - The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients
Recruiting	`NCT01339611` - Education Program for Patients Receiving Oral Anticoagulation	N/A
Completed	`NCT04367831` - Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19	Phase 4
Recruiting	`NCT05711173` - Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)	N/A
Completed	`NCT04824118` - Clotting Parameters After Medical Abortion
Withdrawn	`NCT01810237` - Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy	N/A
Recruiting	`NCT05489588` - The GORE® VIAFORT Vascular Stent Iliofemoral Study	N/A
Completed	`NCT05087108` - Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow	Early Phase 1
Terminated	`NCT04128956` - Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS	Phase 2
Completed	`NCT04439383` - Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
Not yet recruiting	`NCT06452342` - TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study	Phase 4
Recruiting	`NCT06087952` - Leiden Thrombosis Recurrence Risk Prevention	N/A
Completed	`NCT05515120` - Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events	Phase 2/Phase 3
Completed	`NCT03611894` - Comparison of the Radiological Pattern Between the Cerebral Stroke of Arterial and Venous Origin
Completed	`NCT03835780` - The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Recruiting	`NCT05729464` - Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism

NCT number	NCT03613402
Study type	Observational
Source	Alexion Pharmaceuticals
Contact
Status	Withdrawn
Phase
Start date	September 2018
Completion date	January 2020

BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms